- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Alcium-D3 tablets worth Rs 1.5 lakhs seized in Uppal
Telangana: Drugs Control Administration, Telangana has seized Alcium-D3 Tablets (Calcium with Vitamin D3 Tablets) worth Rs. 1.5 lakhs in Kothapet Village, Uppal Mandal, Medchal-Malkajgiri District, which were falsely manufactured and sold under the guise of 'food products/nutraceuticals'.
The said product was falsely manufactured under a 'food license (FSSAI license)' (FSSAI. Lic. No. 10017047000796) and falsely claimed to be a food product/nutraceutical. According to the label composition of the product, it is classified as a drug under the Drugs and Cosmetics Act, 1940.
The product must be manufactured only under a 'drug licence' issued under the Drugs and Cosmetics Act, adhering strictly to the 'Good Manufacturing Practices' (GMP) outlined in Schedule-M of the Drugs Rules.
Additionally, it must meet the quality standards prescribed in the 'Indian Pharmacopoeia' (IP) as mandated.
Dr. B. Lakshmi Narayana, Drugs Inspector, Uppal and Smt. G. IndiraPriyadarshini, Drugs Inspector, Habsiguda carried out the raid under the supervision of Sri. G. Sreenivas, Assistant Director, Shameepet (i/c).
The drugs that are falsely manufactured and sold under a food license are not produced in accordance with 'Good Manufacturing Practices' (GMPs)and often fail to meet the quality standards prescribed in the Indian Pharmacopoeia (IP). Such products pose serious risks to patients' health and may have severe implications.
Manufacturing and selling 'drugs' without a valid 'drug license' is punishable under the Drugs and Cosmetics Act, with imprisonment for up to five years.
Read also: Telangana: Medicines worth Rs 2 crore seized
Medical Dialogues team has recently reported that Drugs Control Administration, Telangana officials, has also seized certain medicines circulating in the market with misleading claims on their labels, stating that they treat, ‘Kidney Stones’, and ‘For Prophylaxis and Treatment of Eye Infections’.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751